In a CY-5 experiment, replacing position 13 with Aib rendered the agonist inactive toward GCGR and slightly altered GLP-1 and GIP activity
I am all about transparency when it comes to dietary supplements: the ingredients should be easy to find, how much of each ingredient, whether it has been third-party tested, as well as what research has been done
However, in the intervention group , 1000 mg of L-Carnitine resulted in a significant reduction in waist circumference
C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study
Semaglutide is a single-pathway GLP-1 receptor agonist, while tirzepatide is a dual GLP-1/GIP receptor agonist that activates two incretin receptors at once
If any lawyers want to hop into the comments and correct me, by all means, please do so